Screener
Immunome IMNM Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Immunome’s reported figures.
The source filing: Immunome’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
FAQ
- What is Immunome's free cash flow?
- Immunome (IMNM) reported free cash flow of -$61.64M in Q1 2026.
- How has Immunome's free cash flow changed year-over-year?
- Immunome's free cash flow decreased by 8.7% year-over-year, from -$56.72M to -$61.64M.
- What is the long-term trend for Immunome's free cash flow?
- Over 3 years (2021 to 2025), Immunome's free cash flow has grown at a 122.1% compound annual growth rate (CAGR), from -$18.31M to -$200.6M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Immunome's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude